Evidence map›Paper›PMID 41315941›Full record

SynthesisBMC cardiovascular disorders2025

Artificial intelligence in cardiovascular diagnostics: a systematic review and descriptive analysis of clinical applications and diagnostic performance.

Ahsanullah Niazai, Hajra Jamil, Maryam Hameed, Sarah Sheikh, Mah Rukh Nisar

Abstract readSystematic Review
In one paragraph

Synthesis in BMC cardiovascular disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Rethinking biomarkers in psychiatry: from etiological uncertainty to actionable prediction.World psychiatry : official journal of the World Psychiatric Association (WPA) · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ahsanullah NiazaiSpinghar Institute of Higher Education, Kabul, Afghanistan. ahsanniazai3@gmail.com.
Hajra JamilServices Institute of Medical Sciences, Lahore, Pakistan.
Maryam HameedServices Institute of Medical Sciences, Lahore, Pakistan.
Sarah SheikhServices Institute of Medical Sciences, Lahore, Pakistan.
Mah Rukh NisarServices Institute of Medical Sciences, Lahore, Pakistan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionArtificial intelligence (AI) is rapidly transforming cardiovascular diagnostics by enhancing early disease detection, risk stratification, and clinical decision-making. Recent studies have shown the effectiveness of AI in analyzing electrocardiograms (ECGs) and cardiac imaging, predicting adverse cardiovascular outcomes, and enabling personalized care. AI models have also demonstrated potential in community-based and population-specific applications, signaling a shift toward data-driven, precision cardiovascular medicine. STUDY

objectiveTo systematically evaluate the clinical applications and diagnostic performance of AI in the detection and risk assessment of cardiovascular diseases.

methodsA systematic search was conducted in PubMed, Google Scholar, and ScienceDirect for English-language articles published between January 2020 and June 2025. Eligible studies included randomized controlled trials and observational designs with free full-text availability. QUADAS-2 tool for diagnostic accuracy studies and the PROBAST for prognostic or risk-prediction models, were used for quality assessment. Of 30 eligible articles, 14 high-quality studies were included.

resultsAcross the included studies, AI-based diagnostic tools demonstrated consistently high performance for cardiovascular disease detection. Reported area under the curve (AUC) values ranged from 0.804 to 0.991, with most ≥ 0.88, indicating robust discriminative accuracy across diverse modalities including ECG analysis, cardiac imaging, and predictive risk modeling. Although formal pooling was not conducted due to methodological heterogeneity, the descriptive synthesis highlighted strong and consistent performance in applications such as heart failure, coronary artery disease, and arrhythmia detection. Variability in study design and reporting limited direct comparison, but overall trends support the potential of AI systems to enhance diagnostic precision across cardiovascular contexts.

conclusionAI-driven diagnostic tools demonstrate consistently high accuracy across cardiovascular applications, supporting their potential to complement clinical decision-making. However, variability in study design and limited external validation highlight the need for standardized evaluation and transparent reporting before widespread clinical integration.

Indexed as

Artificial IntelligenceCardiovascular DiseasesDiagnosis, Computer-AssistedDigital HealthElectrocardiographyHumansIntelligent SystemsPredictive Value of TestsPrognosisReproducibility of ResultsRisk AssessmentArtificial intelligenceCardiovascular diseaseDetectionDiagnosisEarly diagnosisMachine intelligence

Identifiers

PMID41315941
PMCPMC12661670

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.